Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders Sandip BasuThomas C. KweeAbass Alavi Editorial 31 March 2011 Pages: 987 - 991
Whole-body hybrid PET/MRI: ready for clinical use? Osman RatibThomas Beyer Editorial 05 April 2011 Pages: 992 - 995
PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma Shu-Hang NgSheng-Chieh ChanKang-Hsing Fan Original Article 15 February 2011 Pages: 996 - 1008
Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla Julia Fruehwald-PallamarChristian CzernyAndreas M. Herneth Original Article 05 April 2011 Pages: 1009 - 1019
Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity Feng-Yuan LiuChun-Ta LiaoTzu-Chen Yen Original Article 26 February 2011 Pages: 1020 - 1028
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients Caroline RousseauAnne DevillersFrançoise Kraeber-Bodéré Original Article 10 February 2011 Pages: 1029 - 1036
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres Alexander R. HaugVolker HeinemannMarcus Hacker Original Article 10 February 2011 Pages: 1037 - 1045
Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma Rauf HaznedarSahika Z. AkıMustafa Ünlü Original Article 02 February 2011 Pages: 1046 - 1053
Value of the radiolabelled GLP-1 receptor antagonist exendin(9–39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans Beatrice WaserJean Claude Reubi Short Communication 06 January 2011 Pages: 1054 - 1058
18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study Erwin M. WiegmanJan PruimJoachim Widder Short Communication Open access 06 January 2011 Pages: 1059 - 1063
Prognostic value of interim FDG PET/CT in Hodgkin’s lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria Pierre-Yves Le RouxThomas GastinneFrançoise Bodere-Kraeber Original Article 10 February 2011 Pages: 1064 - 1071
Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease Makoto IsozakiYasushi KiyonoHidehiko Okazawa Original Article 02 February 2011 Pages: 1075 - 1082
In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons Christine DeLorenzoMatthew S. MilakRamin V. Parsey Original Article 29 January 2011 Pages: 1083 - 1094
Iterative reconstruction or filtered backprojection for semi-quantitative assessment of dopamine D2 receptor SPECT studies? Walter KochChristine SuessmairGabriele Pöpperl Original Article 02 February 2011 Pages: 1095 - 1103
The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease Benjamin A. ThomasKjell ErlandssonBrian F. Hutton Original Article 19 February 2011 Pages: 1104 - 1119
Prediction of left ventricular remodelling by radionuclide imaging Constantinos D. AnagnostopoulosDennis V. Cokkinos Editorial Commentary 09 April 2011 Pages: 1120 - 1123
Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction Valentina BertiRoberto SciagràAlberto Cuocolo Original Article 15 February 2011 Pages: 1124 - 1131
Vascular time-activity variation in patients undergoing 123I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake Hein J. VerberneDerk O. VerschureArnold F. Jacobson Original Article Open access 02 April 2011 Pages: 1132 - 1138
Diagnostic cutoff points for 123I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson’s disease África MuxíPilar ParedesFrancesca Pons Original Article 04 March 2011 Pages: 1139 - 1146
Focus on time-of-flight PET: the benefits of improved time resolution Maurizio Conti Review Article 13 January 2011 Pages: 1147 - 1157
A new dimension of FDG-PET interpretation: assessment of tumor biology Thomas C. KweeSandip BasuAbass Alavi Review Article 12 January 2011 Pages: 1158 - 1170
Erratum to: Focus on time-of-flight PET: the benefits of improved time resolution Maurizio Conti Erratum 23 February 2011 Pages: 1171 - 1171
Erratum to: Ultrafast nuclear myocardial perfusion imaging on a new gamma camera with semiconductor detector technique: first clinical validation Ronny R. BuechelBernhard A. HerzogPhillip A. Kaufmann Erratum 03 April 2011 Pages: 1172 - 1172
Lingual thyroid imaging with 123I SPECT/CT Laetitia VercellinoNadia Ismaili AlaouiMarie-Elisabeth Toubert Image of the Month 11 March 2011 Pages: 1173 - 1173
FDG PET/CT leads to the detection of metastatic involvement of the heart in non-Hodgkin’s lymphoma A. JulianT. WagnerP. Payoux Image of the Month 23 March 2011 Pages: 1174 - 1174
Guidelines for standard and diuretic renogram in children Isky GordonAmy PiepszRune Sixt Guidelines 19 April 2011 Pages: 1175 - 1188